Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
C$12.48
-0.1%
C$12.49
C$8.01
C$19.69
C$224.06M1.234,018 shs55,513 shs
(FIRE) stock logo
FIRE
(FIRE)
$0.00
$0.00
$0.00
N/AN/AN/AN/A
PBP
Invesco S&P 500 BuyWrite ETF
$21.73
+0.1%
$21.68
$19.41
$24.27
$134.73M0.5338,878 shs22,436 shs
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
+0.16%-13.38%+2.55%-3.18%+42.09%
(FIRE) stock logo
FIRE
(FIRE)
0.00%0.00%0.00%0.00%0.00%
PBP
Invesco S&P 500 BuyWrite ETF
-0.28%0.00%+0.28%-9.95%-2.51%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
1.4344 of 5 stars
2.40.00.00.01.22.51.3
(FIRE) stock logo
FIRE
(FIRE)
N/AN/AN/AN/AN/AN/AN/AN/A
PBP
Invesco S&P 500 BuyWrite ETF
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
2.75
Moderate BuyC$14.7518.19% Upside
(FIRE) stock logo
FIRE
(FIRE)
0.00
N/AN/AN/A
PBP
Invesco S&P 500 BuyWrite ETF
2.75
Moderate Buy$21.73N/A

Current Analyst Ratings Breakdown

Latest IHL, FIRE, CPH, and PBP Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/7/2025
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetHoldC$12.50
(Data available from 5/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
C$19.03M11.77C$3.54 per share3.53C$3.96 per share3.15
(FIRE) stock logo
FIRE
(FIRE)
N/AN/AN/AN/AN/AN/A
PBP
Invesco S&P 500 BuyWrite ETF
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
C$11.41MC$0.9113.78N/A59.92%17.93%7.90%N/A
(FIRE) stock logo
FIRE
(FIRE)
N/AN/A0.00N/AN/AN/AN/AN/AN/A
PBP
Invesco S&P 500 BuyWrite ETF
N/AN/A24.35N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
N/AN/AN/AN/AN/A
(FIRE) stock logo
FIRE
(FIRE)
N/AN/AN/AN/AN/A
PBP
Invesco S&P 500 BuyWrite ETF
$2.3310.72%N/AN/AN/A

Latest IHL, FIRE, CPH, and PBP Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/21/2025
PBP
Invesco S&P 500 BuyWrite ETF
$0.16803/24/20253/24/20253/28/2025
2/21/2025
PBP
Invesco S&P 500 BuyWrite ETF
$0.20742/24/20252/24/20252/28/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
41.22
2.00
2.67
(FIRE) stock logo
FIRE
(FIRE)
N/AN/AN/A
PBP
Invesco S&P 500 BuyWrite ETF
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
1.38%
(FIRE) stock logo
FIRE
(FIRE)
N/A
PBP
Invesco S&P 500 BuyWrite ETF
N/A

Insider Ownership

CompanyInsider Ownership
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
42.00%
(FIRE) stock logo
FIRE
(FIRE)
N/A
PBP
Invesco S&P 500 BuyWrite ETF
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
517.95 millionN/ANot Optionable
(FIRE) stock logo
FIRE
(FIRE)
N/AN/AN/ANot Optionable
PBP
Invesco S&P 500 BuyWrite ETF
N/A6.20 millionN/ANot Optionable

Recent News About These Companies

All About ETFs with Options
Best S&P 500 ETFs: November 2024
PBP Invesco S&P 500 BuyWrite ETF
Invesco S&P 500 UCITS ETF (GBP Hdg) (G500.L)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Cipher Pharmaceuticals stock logo

Cipher Pharmaceuticals TSE:CPH

C$12.48 -0.01 (-0.08%)
As of 04:00 PM Eastern

Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, and Out-Licensed Products among others. The company's geographical segments include Canada and the United States.

(FIRE) stock logo

(FIRE) NASDAQ:FIRE

Sourcefire, Inc. (Sourcefire) is engaged in the business of delivering intelligent cybersecurity technologies. The Company provides a portfolio of solutions that enables commercial enterprises and government agencies worldwide to manage and minimize cybersecurity risks. Sourcefire provides customers with Agile Security that consists of hardware with embedded software, software and cloud-based solutions. It sells its solutions to a customer base that includes Global 2000 companies, global enterprises, the United States and international government agencies, and small and mid-size businesses. During the year ended December 31, 2012, it generated approximately 67% of the Company's revenue from customers in the United States, and 33% of the Company's revenue from customers outside of the United States. As of December 31, 2012, its product revenue and services revenue represented 61% and 39% of its total revenue, respectively.

Invesco S&P 500 BuyWrite ETF NYSEARCA:PBP

$21.73 +0.02 (+0.09%)
As of 04:10 PM Eastern

The Invesco S&P 500 BuyWrite ETF (PBP) is an exchange-traded fund that is based on the Cboe S&P 500 BuyWrite index. The fund tracks an index that uses a covered-call strategy to provide long exposure to the S&P 500 and selling call options thereon. PBP was launched on Dec 20, 2007 and is managed by Invesco.